(CS02) Patient Journeys in Diabetes: Improving Care Through Monitoring Advances for Diabetes Care and Education Specialists

Saturday, August 8, 2026

5:30 PM - 7:30 PM ET

CE: 1.0 CE

Step beyond traditional learning and into the real world of patient-centered diabetes monitoring. This innovative program puts YOU at the intersection of clinical expertise and authentic patient experiences, equipping you with insights and strategies that will reshape the way you care for your patients with diabetes.

Based on immersive, small-group Patient Journey Stations, dive deep into 3 powerful case studies mirroring real-world practice. You will:

• Hear the real voices of patients
• Engage directly with Faculty and colleagues for the exchange of ideas
• Ask questions in an informal setting
• Experience interactive, live panel discussions that bridge patient perspectives with clinical excellence

Take advantage of this opportunity to enhance your clinical practice!

This program is supported by an independent educational grant from Abbott Diabetes Care.

This program is jointly provided by the Association of Diabetes Care & Education Specialists and Medscape.

For more information and to register, please visit: https://www.medscape.org/symposium/cgm-ckm-1

Registration opens, and doors will open at 5:30 PM, with the program beginning promptly at 6:00 PM. Please note that food will be available on a first-come, first-served basis.

Disclosure(s):

Eden M. Miller, DO: Abbott, Bayer, BI, Corcept, Eli Lilly, Insulet, Novo Nordisk, Sanofi,: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP: Abbott: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Dexcom: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Insulet: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Lilly: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Mannkind: Speakers' Bureau (Ongoing); Medtronic: Consultant / Advisory Board (Ongoing); Novo Nordisk: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Tandem: Consultant / Advisory Board (Ongoing)

Davida F. Kruger, MSN, APN-BC, BC-ADM: Abbott, Tandem, Insulet, Sequel,: Research (Ongoing); Dexcom, Cequr, Sequel, Lilly, Novo, Abbott, Tandem, Insulet, Corcept, Sanofi: Speaker/Honoraria (Ongoing); Lilly, Mann Kind, Medtronics, Ascentia, Insulet, Dexcom, Corcept, Abbott Diabetes, Novo Nordsk: Consultant / Advisory Board (Ongoing)

Moderator(s)

Eden M. Miller, DO

Director
Diabetes and Obesity Care LLC

Disclosure(s): Abbott, Bayer, BI, Corcept, Eli Lilly, Insulet, Novo Nordisk, Sanofi,: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Speaker(s)

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP (she/her/hers)

Endocrine Clinical Pharmacy Specialist
Cleveland Clinic Endocrinology & Metabolism Institute

Disclosure(s): Abbott: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Dexcom: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Insulet: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Lilly: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Mannkind: Speakers' Bureau (Ongoing); Medtronic: Consultant / Advisory Board (Ongoing); Novo Nordisk: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Tandem: Consultant / Advisory Board (Ongoing)
Davida F. Kruger, MSN, APN-BC, BC-ADM

Nurse Practitioner
Henry Ford Health

Disclosure(s): Abbott, Tandem, Insulet, Sequel,: Research (Ongoing); Dexcom, Cequr, Sequel, Lilly, Novo, Abbott, Tandem, Insulet, Corcept, Sanofi: Speaker/Honoraria (Ongoing); Lilly, Mann Kind, Medtronics, Ascentia, Insulet, Dexcom, Corcept, Abbott Diabetes, Novo Nordsk: Consultant / Advisory Board (Ongoing)